ProPhase Labs, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Cover
- Cover
Financial Statements
Notes to Financial Statements
Accounting Policies
- Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Commitments and Contingencies (Details)

v3.25.3

Commitments and Contingencies (Details)			3 Months Ended		9 Months Ended
Commitments and Contingencies (Details)	Mar. 31, 2025 USD ($)	Jul. 19, 2022 USD ($)	Sep. 30, 2025 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2025 USD ($)	Sep. 30, 2024 USD ($)	Mar. 31, 2023 site
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
General and administration			$ 4,635,000	$ 6,573,000	$ 13,351,000	$ 20,805,000
Linebacker License Agreements
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Upfront license fee		$ 50,000
License agreement term (in days)		10 days
License or royalty net revenue percentage		3.00%
Royalty expense		$ 250,000
General and administration					0	100,000
Linebacker License Agreements \| Phase 3
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Additional payment of fee		900,000
Linebacker License Agreements \| New Drug Application
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Additional payment of fee		$ 1,000,000
Equivir License Agreement
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
General and administration					0	100,000
Number of sites \| site							8
BE-Smart License Agreement
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
General and administration					$ 0	$ 200,000
Market opportunity value	$ 10,000,000,000
BE-Smart License Agreement \| Minimum
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Estimated number of annual procedures	6,000,000
BE-Smart License Agreement \| Maximum
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Estimated number of annual procedures	$ 7,000,000

- Definition

Additional payment of fee.

+ References

No definition available.

+ Details

Name:	prph_AdditionalPaymentOfFee
Namespace Prefix:	prph_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Collaborative Arrangement, Estimated Annual Procedures

+ References

No definition available.

+ Details

Name:	prph_CollaborativeArrangementEstimatedAnnualProcedures
Namespace Prefix:	prph_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Collaborative Arrangement, Estimated Market Opportunity Value

+ References

No definition available.

+ Details

Name:	prph_CollaborativeArrangementEstimatedMarketOpportunityValue
Namespace Prefix:	prph_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

License Agreement Term

+ References

No definition available.

+ Details

Name:	prph_LicenseAgreementTerm
Namespace Prefix:	prph_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

License Or royalty net revenue percentage.

+ References

No definition available.

+ Details

Name:	prph_LicenseOrRoyaltyNetRevenuePercentage
Namespace Prefix:	prph_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Number Of Sites

+ References

No definition available.

+ Details

Name:	prph_NumberOfSites
Namespace Prefix:	prph_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Upfront license fee.

+ References

No definition available.

+ Details

Name:	prph_UpfrontLicenseFee
Namespace Prefix:	prph_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

+ Details

Name:	us-gaap_GeneralAndAdministrativeExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.

+ References

+ Details

Name:	us-gaap_RoyaltyExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=prph_LinebackerLicenseAgreementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardTypeAxis=prph_PhaseThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardTypeAxis=prph_NewDrugApplicationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=prph_EquivirLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=prph_BESmartLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: